“What are Umbilical Cord Stem Cells?”

Umbilical Cord Stem Cells are found in the umbilical cord and placenta that nourish a baby. At birth, the baby takes as much blood into its body as it needs, and when the umbilical cord is cut and the placenta delivered, some blood remains in these organs.

This blood is removed within 5 minutes of birth, and placed in a special bag for processing. At the laboratory, the stem cells are separated from the other blood cells and plasma, tested for purity, and frozen until they are needed.

“What are Mesenchymal Stem Cells?”

The placenta and umbilical cord structure itself are rich in another type of stem cell derived from the Wharton jelly, the “Mesenchymal stem cell”. This cell, formerly only recognized as a part of bone marrow, appears to be capable of converting into virtually any of the cells of adult tissues. It has already been found to convert into liver and insulin-producing pancreas cells, bone, blood, joint cartilage, tendon, ligament and nerve cells, and has been found to repair damaged kidneys and Parkinson’s Disease brain lesions in rats. We anticipate that this Mesenchymal stem cell, and the cell precursors which descend from it, will be a major part of stem cell therapy in the future.

"Wharton's jelly stem cells (WJSCs) are of great therapeutic potential because large number of cells are easily isolated and may be better tolerated following transplantation because of their low immunogenicity and immune suppression. The cells are a potential powerful device for tissue engineering, cell and gene therapy for a variety of genetic or inherited diseases, as well as for acquired diseases since WJSCs can be induced to form adipose tissue, bone, cartilage, skeletal muscle, cardio myocyte-like cells and neural cells and could be used to treat protein deficiencies, disorders of bone and cartilage and the heart, bone marrow stromal disorders as well as neurological diseases such as Parkinson's disease, multiple sclerosis, cerebrovascular accidents (stroke) as well as perinatal hypoxia/asphyxia and even cerebral palsy." – Curtis L. Cetrulo, M.D. Professor Tufts University School of Medicine and President of the International Cord Blood Society

“Will these stem cells help MY condition?”

In spite of heavy opposition from governmental and pharmaceutical centers of power, a few brave and forward thinking physicians all over the globe are involved with clinical trials of Stem Cells for many conditions. In some cases, there is strong and consistent evidence that stem cells are helpful for a particular condition. In other cases, there may not be enough information yet to know. And in still other cases, stem cells need to be treated or “differentiated” into more specialized cells in order to treat the condition, a process which may or not be available now. By sharing information with doctors throughout the globe, we hope to be able to answer this question for you as soon as possible.

A list of conditions that may be treated with Stem Cells may be found in this excellent book and website: Umbilical Cord Stem Cell Therapy, by David Steenblock, D.O., www.StemCellTherapy.com.

“What about other types of stem cells?”

· Umbilical cord stem cells can convert into any cell type in the body. Other stem cell types may not have this ability.

· Fetal stem cells are extracted from aborted babies, so are ethically questionable.

· Embryonic stem cells are in the news every other day, but they have not been used to cure anyone. They are the darling of the big pharmaceutical corporations because they require difficult, expensive, and patentable processing in order to be useful. They also have a tendency to develop into cancer into the animals in which they have been transplanted.

· Adult stem cells cause immune reactions when they are injected into anyone but the donor, and are generally available only in university research programs.

· Only umbilical cord stem cells are readily available from sources all over the world, do not cause immune problems, and are able to address problems in any organ in your body.

“Is Stem Cell Treatment legal in my country?”

We cannot answer this for every country. However, in most countries, stem cells are not specifically regulated. They are a product which a physician may choose to use as part of his medical practice. In the United States, for example, a physician may use any device or unregulated substance that he has made to treat his patients. We can provide human stem cells to your physician, and teach him how to create a treatment for you. We believe that this is legal, within the scope of the law. We can also help your physician to enroll you and him into an organized program of clinical trials of stem cells, to increase the knowledge of stem cell use world wide. This will also help protect him from suspicious regulators.

USA ONLY: The mesenchymal and umbilical cord blood stem cells used in this study are human cells, tissues, or cellular and tissue-based products (HCT/Ps) as defined in 21 CFR § 1271.3(d). Under 21 CFR Part 1271, HCT/Ps are not subject to licensure or IND requirements if certain criteria are met (21 CFR § 1271.10).  

These requirements include autologous use (use by the cell donor), or if used for other patients, the HCT/Ps must be “not more than minimally manipulated” and labeled for use for “homologous use only”.  They may also not be used for a purpose requiring their “metabolic” activity.

SOUTH AMERICA: StemLab S.A. mesenchymal and umbilical cord stem cells shipped to the United States of America have not been “more than minimally manipulated”.  StemLab S.A. labels and intends its cells which are used within the United States of America only for homologous and non-metabolic purposes.  StemLab S.A. does not interfere with the practice of medicine by individual physicians who use StemLab products, and who may do so according to their own medical training and informed choice.

"What is the US FDA law regarding stem cells?"

TITLE 21 part 1271 of the US FDA law

“Where can I get Stem Cell treatment?”

StemTech Labs can provide unprocessed, undifferentiated stem cells to your physician, who can enroll you into a program of human clinical trials, and administer the cells to you at his office. Or, we can refer you to another doctor who may be willing to administer the cells to you. We also offer stem cell administration by our own licensed physicians in Ecuador, as well as health-vacation packages of advanced medical diagnosis and treatments for many hard-to-treat conditions. These packages include hotel stay and stem cell treatment, as well as other medical assessments and treatments.

“Are there any problems resulting from receiving stem cells?”

No significant adverse reactions to StemTech Labs stem cells, or other umbilical cord stem cells, have been reported. Some patients have had a short period of chills and fever, lasting for a few hours. This is a result of cytokine release from the stored cells. One patient with MS reported an improvement of her symptoms, followed by a bothersome increase in sensitivity of her nervous system.

Over 5,000 umbilical cord stem cell transplants have been given since 1988, mostly to children with leukemia, instead of a bone marrow transplant. There have been little or no adverse reactions reported from these transplants. There have been problems with the procedure, but these problems are mostly for Graft vs Host disease (see below) due to the pre-treatment with radiation and chemicals to destroy the immune system, and not from the stem cells themselves. Umbilical cord stem cells do not seem to cause any immune problems in the recipient, unlike adult stem cells, and they do not cause cancer, like embryonic stem cells. StemTech Labs tests its stem cells for blood borne infections in an independent lab.

There has been one case of a non-cancerous collection of stem cells forming as a result of an injection of stem cells into a kidney, performed in Thailand. While this collection was found by physicians, and the kidney was removed for fear that it was cancer, the cells do not seem to have had any direct effect on the patient’s health.

What about Graft vs Host Disease?

Graft vs. Host Disease, or GVHD, is a common side effect of bone marrow transplantation, and of stem cell replacement of bone marrow, usually used for cancers such as leukemia. Sometimes this disease, which is totally caused by medical treatment, can be fatal. Even with a perfect tissue match, there is still a 50% incidence of GVHD in bone marrow/umbilical cord stem cell transplant patients. For stem cell transplants facilities, GVHD is thus a very important problem, and stem cell transplant doctors in the USA, most of whom are ONLY doing transplants for cancer, thus are very concerned about GVHD. In fact, much of the medical literature about umbilical cord blood stem cell transplantation is primarily discussions of GVHD.

In a patient who has NOT had their immune system and bone marrow obliterated by radiation and/or drugs, however, GVHD DOES NOT OCCUR. It doesn’t happen. It is difficult for most hospital and research stem cell transplant physicians to understand this, because they NEVER give stem cell treatments without immune obliteration. But, for non-cancer, non-bone marrow problems, it is not necessary to do immune obliteration, so in our Stem Cell Transplant patients, we never see GVHD.

“How are Stem Cell treatments given?”

In a brief, in-office procedure, the stem cells can be given through an IV line into a vein, or injected under the skin. Stem cells have the ability to travel throughout the body to find the sites of problems, and then to multiply at those locations, and repair the problem. Like any other injections, there may be a chance of bruising, pain, bleeding or infection at the site. Specialized cases, such as providing nerve stem cells to the spinal cord, brain, or retina, may require injection of the cells into the spinal canal, or behind the eye. It is still unclear what the best route of administration is for some types of problems. It may be necessary to work with a specialist in order to deliver the cells to the right location, but stem cells do have an amazing ability to find a problem, migrate to the site of the problem, multiply, differentiate into the proper cell types, and repair the problem.

“How much do Stem Cells cost?”

Currently, prices vary from $100,000 for stem cell treatment for MS at the University of Texas, to $25,000 per treatment for fetal stem cells in Ukraine and Dominican Republic, to $20,000 for umbilical cord stem cells in Africa, and $12-$15,000 in Mexico.

Starting July 15, 2008 or earlier, StemTech Lab will be providing undifferentiated umbilical cord stem cells for the introductory price of only $5000 US, plus shipping. This is as little as 20% of the price of other companies’ stem cell treatments.

We at StemTech labs have a commitment to provide top quality, safe and effective stem cells to those who need them, at a price which they can afford.  Most companies see the demand for these cells, and charge whatever they can get.  We believe that by lowering the cost, without sacrificing quality, we will be able to provide these life changing stem cells to many more people, thus improving many more lives."

In the near future, we will be providing differentiated stem cells for more specialized treatment of nerve, eye and brain disorders, diabetes, liver failure, cancer and other illnesses.

"How do stem cells find their way in the body?  How can they identify damaged areas or areas that need repair?"

Cells have many identifying markers that they carry on their outside membrane.  Most of these markers are proteins, some are combinations of sugar molecules, and some are mixtures of both.  Some of these markers are familiar as the ABO and Rh blood type markers.  Another group of markers are the HLA markers (Human Lymphocyte Antigens) that identify our cells as “Self” or “Foreign”.  These are the “Tissue Type” markers that are currently so important in transplants.  If a person receives a transplant of a different tissue type, he must take anti-rejection drugs for the rest of his life, to keep his own cells from attacking the “foreign” tissue cells.

Besides the “self or non-self” markers, there are also markers on cells that identify them as a particular cell function, ie, cardiac muscle cells, liver cells, or blood cells.  Experiments with fetal animal cells show that if you take cardiac muscle cells and liver cells, and mix them up, the cells will migrate toward their own cell type, and when the like cells find each other, they soon begin to form a primitive organ.  The heart cells even start beating! 

Further experiments where fetal lamb heart and liver cells were mixed with adult human liver and heart cells showed that the heart cells sought out the heart cells, and the liver cells sought out the liver cells.  The primitive organs formed were made up of part lamb and part human cells. Furthermore, the young animal cells somehow activated the older human cells, and made them more active.

Further experiments have shown that injections of radioactively labeled fetal animal cells in humans traveled throughout the bloodstream, but ended up in the appropriate human organ. They even have the ability to cross the blood brain barrier, which protects the sensitive brain from most cells, chemicals and other substances in the blood.  These experiments support the very successful fetal animal cell therapy (“Live Cell Therapy”) which is done in Europe and Mexico, but is illegal in the US. 

The ability of a cell to travel toward a certain chemical stimulus (such as tissue damage, or a particular type of cell) is known as chemotaxis, and is a commonly known cell characteristic.  Some of the most common forms of chemotaxis involve inflammation, or tissue damage, calling in fibroblasts and blood cells to fight infection and repair the damage.  Fibroblasts are fairly primitive cells which maintain the extracellular matrix, and also build connective tissues. Under the microscope, most stem cells are indistinguishable from fibroblasts, so it is not difficult to believe that they preserve some of the same chemotactic ability to find damaged areas that the fibroblasts have.

Recent experiments with labeled human umbilical cord stem cells have also showed that they have the ability to seek out, and find damaged areas in animals’ tissues and brains, again crossing the blood brain barrier when needed.

A final thing to consider is that the full pattern of the body is not coded in the DNA. It exists in the etheric/electromagnetic “morphogenetic fields” permeating and surrounding the body.  These fields have been visualized and photographed via the Kirklian techniques, and can be measured with electromagnetic sensors, as well as radioesthetic ones, such as dowsing rods, pendulums, and the like.  Some of the effects of the electromagnetic fields of the body are described in the orthopedic surgeon Dr. Robert Becker’s book The Body Electric.  These fields map the perfection or ideal image of a body.  Cells contain the genetic (DNA) programming to produce the biochemical means (proteins and enzymes) of following the morphogenetic fields to produce a body.  Experiments with salamanders have shown that cells which hold the DNA code for the entire animal can be induced to produce a limb, or a limb on top of a limb, by disruptions in the morphogenetic field.

It appears that stem cells have the intrinsic ability to follow the morphogenetic fields of the body, to copy and produce the idea form and function of that body.  If there is a disruption or anomaly in that form or function, stem cells, even from a different body, have the ability to seek out that anomaly and then seek to repair it.  Ormus, or White Gold, seems to increase the ability of stem cells to follow the morphogenetic fields.

See the photos of Tut the Cat, who regrew a tail when provided with Ormus.  You can see in one photo a callus of stem cells actively building new tail—bones, nerves, muscles, blood vessels, and skin.

"Why are newborn baby stem cells better than our own stem cells?"

The genetic information in a cell is encoded in a series of long strands of DNA, called Chromosomes.  Each chromosome has a tail at each end, sort of like the tips of a shoelace, called a telomere.  Telomeres are composed of condensed, repeating rungs of DNA which form a loop at the end.  As cells repeatedly divide throughout the lifetime of a cell, the telomeres become shorter and shorter. 

Telomeres at the ends of chromosomes.  – From Wikipedia.

Eventually, if a telomere becomes too short, the cell dies rather than lose pieces of actual genetic code.

There are enzymes which rebuild the telomeres in some cells, especially in stem cells, so that they may continue to divide indefinitely and produce more stem cells. Still, the chances of DNA being damaged and its coding inaccurate, and also having short telomeres, increases with age.

Young Serum

A study in India where unprocessed umbilical cord blood was transfused into sick patients showed that almost all of the patients made significant improvements in their health.  Thus, the newborn cells were superior to their own cells.

Another study, in the prestigious Science journal Nature, showed that old cells got younger just by being exposed to young blood serum.  For this reason, we our stem cells are exposed to their own serum at all stages of processing, including the thawing and infusion process.

Stem cell treatment starting at: $2,500